XML 20 R70.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Guarantor And Non-Guarantor Financial Information (Schedule Of Condensed Consolidating Statements Of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Net income (loss), including noncontrolling interests $ 111,966 $ 68,744
Other adjustments 109,054 181,829
Net cash provided by (used in) operating activities 221,020 250,573
Capital expenditures (150,107) (106,122)
Distributions from equity investments, net 2,045 (1,106)
Proceeds from sale of Cal Dive common stock   3,588
Decrease (increase) in restricted cash 2,660 863
Net cash used in investing activities (145,402) (102,777)
Borrowings of debt 400,000  
Repayments of debt (358,604) (113,485)
Deferred financing costs (6,485) (9,014)
Repurchases of common stock (7,510) (1,012)
Excess tax benefit from stock-based compensation (657) (1,196)
Exercise of stock options, net and other 372 439
Net cash provided by (used in) financing activities 27,116 (124,268)
Effect of exchange rate changes on cash and cash equivalents 304 (424)
Net increase in cash and cash equivalents 103,038 23,104
Balance, beginning of year 546,465 391,085
Balance, end of period 649,503 414,189
Helix [Member]
   
Net income (loss), including noncontrolling interests 110,330 67,117
Equity in earnings of affiliates (157,696) (107,036)
Other adjustments (23,636) 21,261
Net cash provided by (used in) operating activities (71,002) (18,658)
Capital expenditures (1,635) (15,699)
Proceeds from sale of Cal Dive common stock   3,588
Net cash used in investing activities (1,635) (12,111)
Borrowings of debt 400,000  
Repayments of debt (356,195) (111,191)
Deferred financing costs (6,485) (9,014)
Repurchases of common stock (7,510) (1,012)
Excess tax benefit from stock-based compensation (657) (1,196)
Exercise of stock options, net and other 372 1,652
Intercompany financing 131,741 162,868
Net cash provided by (used in) financing activities 161,266 42,107
Net increase in cash and cash equivalents 88,629 11,338
Balance, beginning of year 495,484 376,434
Balance, end of period 584,113 387,772
Guarantors [Member]
   
Net income (loss), including noncontrolling interests 117,746 76,691
Equity in earnings of affiliates (6,295) 1,468
Other adjustments 146,623 180,193
Net cash provided by (used in) operating activities 258,074 258,352
Capital expenditures (131,879) (76,331)
Decrease (increase) in restricted cash 2,660 863
Net cash used in investing activities (129,219) (75,468)
Intercompany financing (128,514) (183,765)
Net cash provided by (used in) financing activities (128,514) (183,765)
Net increase in cash and cash equivalents 341 (881)
Balance, beginning of year 2,434 3,294
Balance, end of period 2,775 2,413
Non-Guarantors [Member]
   
Net income (loss), including noncontrolling interests 47,823 30,448
Other adjustments (11,702) (14,149)
Net cash provided by (used in) operating activities 36,121 16,299
Capital expenditures (16,593) (14,092)
Distributions from equity investments, net 2,045 (1,106)
Net cash used in investing activities (14,548) (15,198)
Repayments of debt (2,409) (2,294)
Exercise of stock options, net and other   (1,213)
Intercompany financing (5,400) 15,477
Net cash provided by (used in) financing activities (7,809) 11,970
Effect of exchange rate changes on cash and cash equivalents 304 (424)
Net increase in cash and cash equivalents 14,068 12,647
Balance, beginning of year 48,547 11,357
Balance, end of period 62,615 24,004
Consolidating Entries [Member]
   
Net income (loss), including noncontrolling interests (163,933) (105,512)
Equity in earnings of affiliates 163,991 105,568
Other adjustments (2,231) (5,476)
Net cash provided by (used in) operating activities (2,173) (5,420)
Intercompany financing 2,173 5,420
Net cash provided by (used in) financing activities $ 2,173 $ 5,420